Abera Bioscience Gets Approval to Begin Phase 1 Vaccine Trial
Abera Bioscience received approval to begin a Phase 1 clinical study of vaccine candidate Ab-01.12.
Related stories
Democrats Win Control of Congress in 2026 US Midterm Elections
H impact | REGULATION | Nov 04, 2026, 08:35 AM UTC
Argentina Government to Withdraw Proposed Tax on CEDEAR Sales
The government will withdraw an article proposing an income tax on CEDEAR sales, following controversy.
L impact | REGULATION | Nov 04, 2026, 08:24 AM UTC
FDA Grants Therapy Designation to Idorsia
The FDA granted a therapy designation to Idorsia; its shares were up 1.66%.
M impact | REGULATION | Nov 04, 2026, 08:16 AM UTC
Bangladesh Wage Board Meets as Garment Worker Protests Continue
The board will review a new wage structure for the garment industry as protests enter their fifth day. Workers are demanding a 140% pay increase, and clashes with police have occur
L impact | REGULATION | Nov 04, 2026, 08:16 AM UTC
Democrats Win Control of Both Houses in US Midterm Elections
Reuters reports that Democrats won control of both the House and Senate in the US midterm elections.
M impact | REGULATION | Nov 04, 2026, 08:06 AM UTC
EU Imposes Five-Year Antidumping Duties on Chinese PET Spunbond
The EU imposed antidumping duties on Chinese PET spunbond for five years.
M impact | REGULATION | Nov 04, 2026, 08:05 AM UTC